Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,430
Total Claims
$797K
Drug Cost
510
Beneficiaries
$1,562
Cost/Patient
Risk Score Breakdown 36/100
Score components are additive. Read full methodology
Peer Comparison vs. 16,767 Hospitalist providers
-83%
Opioid rate vs peers
0.5% vs 3.0% avg
+266%
Cost per patient vs peers
$1,562 vs $427 avg
+136%
Brand preference vs peers
12.4% vs 5.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.5%
Opioid Rate
94
Opioid Claims
$4,082
Opioid Cost
11.7%
Long-Acting Rate
Brand vs Generic
Brand: 2,278 claims · $526K
Generic: 16,106 claims · $268K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 558 | $111K |
| Pimavanserin Tartrate | 30 | $62K |
| Posaconazole | 20 | $52K |
| Dulaglutide | 45 | $40K |
| Rivaroxaban | 139 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 55 | $18K |
| Linaclotide | 28 | $18K |
| Dextromethorphan Hbr/Quinidine | 17 | $12K |
| Empagliflozin | 46 | $11K |
| Lipase/Protease/Amylase | 21 | $11K |
| Insulin Lispro | 43 | $10K |
| Chlorpromazine Hcl | 49 | $8,901 |
| Atorvastatin Calcium | 1,090 | $8,345 |
| Insulin Detemir | 24 | $7,924 |
| Cariprazine Hcl | 21 | $7,854 |
Prescribing Profile
Patient Profile
81
Avg Age
68%
Female
2.45
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About